Literature DB >> 32540257

A tearfully painful darkness.

Lakshmi Leishangthem1, Shannon Beres2, Heather E Moss3, John Chen4.   

Abstract

A 70-year-old woman presented with new onset of left eye and facial pain. Ophthalmic and neurological examinations, magnetic resonance imaging brain, erythrocyte sedimentation rate, and C-reactive protein were unrevealing. A few days later, she developed vision loss in her left eye. Examination revealed decreased visual acuity with a relative afferent pupillary defect in the left eye and a diffuse mild swelling of the left optic nerve head. Repeat magnetic resonance imaging showed T2 hyperintensity and enhancement of the intraorbital optic nerve and surrounding tissues with no other intracranial abnormalities. Serum studies showed elevated myelin oligodendrocyte glycoprotein IgG titer. She was treated with IV methylprednisolone 1000 mg daily for 3 days and was discharged on prolonged prednisone taper with return of vision to baseline.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  MOG IgG; headache; myelin oligodendrocyte glycoprotein; optic neuritis; trigeminal pain

Mesh:

Substances:

Year:  2020        PMID: 32540257      PMCID: PMC8136591          DOI: 10.1016/j.survophthal.2020.06.002

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  18 in total

Review 1.  Clinical Characteristics and Treatment of MOG-IgG-Associated Optic Neuritis.

Authors:  Deena A Tajfirouz; M Tariq Bhatti; John J Chen
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-26       Impact factor: 5.081

Review 2.  Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis.

Authors:  John J Chen; M Tariq Bhatti
Journal:  Curr Opin Neurol       Date:  2020-02       Impact factor: 5.710

3.  Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults.

Authors:  Alvaro Cobo-Calvo; María Sepúlveda; Hyacintha d'Indy; Thais Armangué; Anne Ruiz; Elisabeth Maillart; Caroline Papeix; Bertrand Audoin; Helene Zephir; Damien Biotti; Jonathan Ciron; Francoise Durand-Dubief; Nicolas Collongues; Xavier Ayrignac; Pierre Labauge; Eric Thouvenot; Alexis Montcuquet; Romain Deschamps; Nuria Solà-Valls; Sara Llufriu; Yolanda Blanco; Jerome de Seze; Sandra Vukusic; Albert Saiz; Romain Marignier
Journal:  J Neurol       Date:  2019-01-03       Impact factor: 4.849

4.  Prodromal headache in MOG-antibody positive optic neuritis.

Authors:  Susanna Asseyer; Josh Hamblin; Silvia Messina; Romina Mariano; Nadja Siebert; Rosie Everett; Wilhelm Küker; Judith Bellmann-Strobl; Klemens Ruprecht; Sven Jarius; Maria Isabel Leite; Alexander U Brandt; Friedemann Paul; Jacqueline Palace
Journal:  Mult Scler Relat Disord       Date:  2020-01-25       Impact factor: 4.339

Review 5.  Recent Advances in Giant Cell Arteritis.

Authors:  M Guevara; C S Kollipara
Journal:  Curr Rheumatol Rep       Date:  2018-04-02       Impact factor: 4.592

6.  Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study.

Authors:  Alvaro Cobo-Calvo; Anne Ruiz; Elisabeth Maillart; Bertrand Audoin; Helene Zephir; Bertrand Bourre; Jonathan Ciron; Nicolas Collongues; David Brassat; Francois Cotton; Caroline Papeix; Francoise Durand-Dubief; David Laplaud; Romain Deschamps; Mikaël Cohen; Damien Biotti; Xavier Ayrignac; Caroline Tilikete; Eric Thouvenot; Bruno Brochet; Cecile Dulau; Thibault Moreau; Ayman Tourbah; Pierre Lebranchu; Laure Michel; Christine Lebrun-Frenay; Alexis Montcuquet; Guillaume Mathey; Marc Debouverie; Jean Pelletier; Pierre Labauge; Nathalie Derache; Marc Coustans; Fabien Rollot; Jérôme De Seze; Sandra Vukusic; Romain Marignier
Journal:  Neurology       Date:  2018-04-25       Impact factor: 9.910

Review 7.  Treatment Approaches for MOG-Ab-Associated Demyelination in Children.

Authors:  Yael Hacohen; Brenda Banwell
Journal:  Curr Treat Options Neurol       Date:  2019-01-22       Impact factor: 3.598

8.  Cranial nerve involvement in patients with MOG antibody-associated disease.

Authors:  Alvaro Cobo-Calvo; Xavier Ayrignac; Philippe Kerschen; Philippe Horellou; Francois Cotton; Pierre Labauge; Sandra Vukusic; Kumaran Deiva; Ché Serguera; Romain Marignier
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-02-01

Review 9.  Neuromyelitis Optica Spectrum Disorder and Anti-MOG Syndromes.

Authors:  Marco A Lana-Peixoto; Natália Talim
Journal:  Biomedicines       Date:  2019-06-12

10.  The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults.

Authors:  C L de Mol; Yym Wong; E D van Pelt; Bha Wokke; Tam Siepman; R F Neuteboom; D Hamann; R Q Hintzen
Journal:  Mult Scler       Date:  2019-05-16       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.